Abbott pharmaceuticals news
In an SEC filing, Abbott disclosed that it will restructure and reduce headcount by about 1,000 (1.5%)
Gathering data...
Products & Solutions
About Biocentury
Contact
Privacy & Legal
- Follow Us
Gathering data...
In an SEC filing, Abbott disclosed that it will restructure and reduce headcount by about 1,000 (1.5%)